Daniel Hodson

Daniel Hodson studied Medicine at Cambridge University and then clinical medicine at Oxford University. He subsequently trained as a clinical haematologist with a special interest in lymphoid malignancies. During his haematology training he undertook a PhD in molecular immunology at the Babraham Institute in Cambridge under the supervision of Dr Martin Turner, where he studied the contribution of post-transcriptional regulation to the normal lymphocyte development. In 2010 he moved to the National Cancer Institute, USA, as a post-doctoral fellow in the lab of Dr Lou Staudt, where he developed expertise in the application of functional genomics to the study of B cell lymphomas. In 2015 he returned to Cambridge as a Medical Research Council Clinician Scientist and group leader in CSCI and the Department of Haematology. In 2021 he was awarded a CRUK Senior Cancer Research Fellowship. His group researches the molecular mechanisms that underlie lymphomagenesis. Professor Hodson also holds an honorary consultant contract in the Haematology Department at Cambridge University NHS Hospitals Trust. In 2026 he was named Professor of Lymphoma Biology at the Department of Haematology.